These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Hoogstraten B, George SL, Samal B, Rivkin SE, Costanzi JJ, Bonnet JD, Thigpen T, Braine H. Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510 [Abstract] [Full Text] [Related]
3. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone. Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT. Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314 [No Abstract] [Full Text] [Related]
5. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer. De Lena M, Brambilla C, Morabito A, Bonadonna G. Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104 [Abstract] [Full Text] [Related]
6. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project. Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S. Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975 [Abstract] [Full Text] [Related]
11. Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin. Casper ES, Guidera CA, Bosl GJ, Hakes TB, Kaufman RJ, Shurgot B, Kinne DW. Breast Cancer Res Treat; 1987 Jun; 9(1):39-44. PubMed ID: 3593990 [Abstract] [Full Text] [Related]
12. Chemotherapy of advanced breast cancer. Results of a controlled trial comparing two three-drug regimens. Chauvergne J, Berlie J, Clavel B, Guerrin J, Gary-Bobo J, Brulé G, Klein T, Pommatau E, Carton M. Eur J Cancer (1965); 1978 Sep; 14(9):911-7. PubMed ID: 361415 [No Abstract] [Full Text] [Related]
13. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT, Palshof T. Prog Clin Biol Res; 1977 Sep; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
14. [Cytostatic therapy in metastatic breast cancer]. Rainer H, Lenzhofer R. Wien Klin Wochenschr; 1984 Jun 22; 96(13):517-21. PubMed ID: 6548066 [Abstract] [Full Text] [Related]
15. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S. Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501 [Abstract] [Full Text] [Related]
16. Breast cancer 1984: state of the art. Sledge GW. Indiana Med; 1984 Dec 01; 77(12):935-9. PubMed ID: 6394645 [No Abstract] [Full Text] [Related]
17. Hormono-chemotherapy in the treatment of advanced breast cancer. Cavalli F, Goldhirsch A, Joss R, Brunner KW. J Steroid Biochem; 1985 Dec 01; 23(6B):1129-34. PubMed ID: 3912617 [Abstract] [Full Text] [Related]
18. Chemotherapy of breast cancer. Mitchell MS. Conn Med; 1975 Jan 01; 39(1):4-5. PubMed ID: 1109851 [No Abstract] [Full Text] [Related]
19. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. Ahmann DL, Bisel HF, Eagan RT, Edmonson JH, Hahn RG. Cancer Chemother Rep; 1974 Jan 01; 58(6):877-82. PubMed ID: 4614896 [No Abstract] [Full Text] [Related]
20. Adjuvant treatment of cancer. II. Breast carcinoma. Viola MV, Nystrom JS. Conn Med; 1977 Jun 01; 41(6):333-5. PubMed ID: 872584 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]